Varian Medical releases new Velocity cancer imaging software

Varian Medical (NYSE:VAR) said today it launched an FDA-cleared version of its Velocity cancer imaging software, including a new Rapidsphere module.

The newly launched Velocity 4.0’s Rapidsphere module is designed for Y90 selective internal radiation therapy dosimetry analysis and provides improved information on tumor responses and normal-tissue toxicity for patients undergoing SIRT, the Palo Alto, Calif.-based company said.

The Velocity 4.0 software includes the company’s Velocity M3i multi-modality motion imaging component, the Velocity Aria sync component and the Velocity tumor & dose tracking component.

“At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients. Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor’s response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT,” Varian oncology systems biz prez Kolleen Kennedy said in a press release.

Last week, Brainlab said it inked a deal with Varian looking to support interoperability between Brainlab’s ExacTrac and Varian’s Clinac platform, TrueBeam and Edge systems.

The post Varian Medical releases new Velocity cancer imaging software appeared first on MassDevice.

from MassDevice https://ift.tt/2GNdGsy